Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients

1 Jan 2018

Abstract excerpt

Histone deacetylases modulate the dynamic balance of histone acetylation and deacetylation in cells, which participate in epigenetic regulations. Accumulated evidence has demonstrated that histone deacetylases are associated with angiogenesis, cell proliferation and survival in a variety of human cancers. However, the expression and distinct prognostic value of histone deacetylases in ovarian cancer have not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to Peptidase Inhibition and Analysis
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30519361
DOI: 10.7150/jca.26780

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer PatientsPMID 30519361Read ↗

Potential of histone deacetylase inhibitors for the therapy of ovarian cancerSemantic proximity Read ↗

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer MetastasisSemantic proximity Read ↗

Novel Histone Acetylation Regulators: Mediators of Tumor Microenvironment Infiltration and Prognostic Model in Cervical Cancer PatientsSemantic proximity Read ↗

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian CancerSemantic proximity Read ↗

HDAC6 and Ovarian CancerSemantic proximity Read ↗

HDAC11: A novel target for improved cancer therapySemantic proximity Read ↗

Targeting histone deacetylases for the treatment of cancer and inflammatory diseasesSemantic proximity Read ↗

A novel histone acetylation-associated gene signature with prognostic value in Ewing SarcomaSemantic proximity Read ↗

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.Semantic proximity Read ↗

Histone deacetylase 6 in cancerSemantic proximity Read ↗

Mechanisms of HDACs in cancer developmentSemantic proximity Read ↗

The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.